Keratoconjunctivitis Sicca: all 797 studies
Page 6 of 8. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Dry Eye Evaluation System Based on BioinformaticsStatus unknownNCT04109170
- Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract SurgeryCompletedNCT04100031Not applicable
- Senofilcon A Lenses in Moderate to Severe Dry Eye DiseaseStatus unknownNCT04096898Not applicable
- Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry EyeCompletedNCT04093037Not applicable
- Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae MyceliaCompletedNCT04063735Not applicable
- Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye PatientsCompletedNCT04063644Not applicable
- The Influences of Dry Eye Disease on Optical QualityCompletedNCT04043949
- A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual OcclusionCompletedNCT04022382Not applicable
- The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)Status unknownNCT04000789Not applicable
- Efficacy and Safety of Hydrolysed Red Ginseng Extract on Dry EyeStatus unknownNCT03992287Not applicable
- Levocarnitine for Dry Eye in Sjogren's SyndromeCompletedNCT03953703Phase 2
- Effect of Lifitegrast 5% on Tear Film MarkersWithdrawnNCT03952481Phase 4
- The Effect of Punctal Plugs on Ocular Surface After Povidone-Iodine Preparation of Intravitreal InjectionCompletedNCT03945071Not applicable
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular SurfaceCompletedNCT03923244Not applicable
- Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface InflammationCompletedNCT03907865Phase 4
- Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye DiseaseStatus unknownNCT03888183Phase 4
- Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye DiseaseCompletedNCT03878628Early Phase 1
- The Effect Of Lifitegrast On Refractive Accuracy And Symptoms In Dry Eye Patients Undergoing Cataract SurgeryCompletedNCT03866629
- Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren SyndromeCompletedNCT03865888Phase 3
- Effect of Thermal Pulsation System (Lipiflow) Treatment for Ocular Surface Disease Due to Meibomian Gland DysfunctionCompletedNCT03843983Not applicable
- Study of TOP1630 for Dry Eye SyndromeCompletedNCT03833388Phase 2/3
- Effects of RP101 in Post-menopausal Women With Dry Eye SyndromeCompletedNCT03821415Phase 2
- Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry EyeStatus unknownNCT03815539Not applicable
- A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi®CompletedNCT03803748Not applicable
- To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical PerformanceTerminatedNCT03803722Not applicable
- Autologous Plasma Treatment for Severe Dry Eye PatientsWithdrawnNCT03768115Early Phase 1
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.CompletedNCT03723811Phase 2
- Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.CompletedNCT03723798Phase 2
- A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual OcclusionCompletedNCT03709641Not applicable
- Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye DropsCompletedNCT03706443Not applicable
- Efficacy Study of Ketorolac and HPMC to Treat Dry EyeWithdrawnNCT03693183Phase 2
- Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.Status unknownNCT03691636Not applicable
- Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry EyeCompletedNCT03676335Phase 2
- The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye SyndromeCompletedNCT03666884Phase 4
- DRy Eye Outcome and Prescription StudyStatus unknownNCT03652415
- Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract SurgeryCompletedNCT03640351Not applicable
- Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry EyeCompletedNCT03617315Not applicable
- Comparison Between Rebamipide 2% Versus Autologous SerumCompletedNCT03608761Phase 4
- Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye SyndromeCompletedNCT03576300
- A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye DiseaseCompletedNCT03527212Phase 3
- Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye DiseaseCompletedNCT03519815Not applicable
- Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma DropsStatus unknownNCT03515187Phase 3
- Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye DiseaseCompletedNCT03492541Not applicable
- Self-care Management Program for Dry Eye Disease Patients Using the heiQStatus unknownNCT03467490Not applicable
- Functional MRI Study of Cortical Modifications to Light Stimulation in Patients With PhotophobiaStatus unknownNCT03464357Not applicable
- Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye SyndromeCompletedNCT03461575Phase 3
- REMOGEN® Omega Versus Cationorm® in the Treatment of Patients Suffering From Dry EyeTerminatedNCT03460548Not applicable
- Effect of Lifitegrast on Dry Eye Disease Signs and SymptomsCompletedNCT03451396Phase 4
- Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry EyeStatus unknownNCT03436576Phase 3
- Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens WearersWithdrawnNCT03431272Phase 4
- Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)CompletedNCT03418259Not applicable
- Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye DiseaseWithdrawnNCT03408015Phase 4
- Corneal Tear Film Imaging of the Cornea Before and After Restasis TherapyStatus unknownNCT03403023Not applicable
- Effect of Lipid Based Eye Drops on Tear Film Lipid Layer ThicknessCompletedNCT03399292
- Repository Corticotropin Injection in Keratoconjunctivitis SiccaWithdrawnNCT03398018Phase 4
- Fingerprick Autologous Blood (FAB) in Severe Dry Eye Disease (DED)Status unknownNCT03395431Not applicable
- Influencing Factors on Dry Eye Syndrome and Ocular Surface DiseaseCompletedNCT03364322
- Impact of Breathing Exercises and Meditation on Quality of Life in Dry Eye Disease Patients: A Pilot StudyStatus unknownNCT03345381Not applicable
- Closed Eye Neutrophils in Dry Eye DiseaseCompletedNCT03332342Not applicable
- Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's SyndromeCompletedNCT03319420Phase 4
- Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland DysfunctionCompletedNCT03318874Phase 4
- Corneal Epithelial Stem Cells and Dry Eye DiseaseCompletedNCT03302273Not applicable
- Investigating the Effect of At Home Thermal Therapy on Dry Eye Patients With Meibomian Gland DysfunctionStatus unknownNCT03291704Not applicable
- Single Center, Prospective, Randomized, Controlled, Non-significant RiskWithdrawnNCT03286166
- IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGDCompletedNCT03265652Not applicable
- Effect of an Oral Supplement Containing Omega-3 and Omega-6 on Dry Eye SymptomsCompletedNCT03265327Not applicable
- The Effect of Ablation Depth on Dry Eye After LASIK Treatment of MyopiaCompletedNCT03228784Not applicable
- Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's SyndromeCompletedNCT03226444Phase 1/2
- Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye DiseaseCompletedNCT03216096Phase 1
- Effects of Two Tear Substitutes in Patients With Dry Eye SyndromeCompletedNCT03211351Not applicable
- Laser Acupuncture for Dry EyeStatus unknownNCT03204903Not applicable
- Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry EyeCompletedNCT03183089Phase 4
- Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye SyndromeStatus unknownNCT03162094Phase 1/2
- Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye SyndromeCompletedNCT03161080Not applicable
- LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS PatientsStatus unknownNCT03140111Not applicable
- Walnut Shell Glasses Moxibustion for Dry Eye SyndromeStatus unknownNCT03116776Not applicable
- HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)CompletedNCT03108664Phase 3
- Allogeneic Versus Autologous Serum Eye DropsCompletedNCT03085290Not applicable
- Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry EyeCompletedNCT03074344Not applicable
- Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)CompletedNCT03061578
- Lamelleye vs Comparator for the Treatment of Dry Eye DiseaseCompletedNCT03052140Not applicable
- Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye DiseaseCompletedNCT03048526Not applicable
- Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry EyeCompletedNCT03012698Not applicable
- Effect of Intense Pulse Light (IPL) Treatment on Tear Film OsmolarityStatus unknownNCT02992535Phase 4
- Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye SyndromeStatus unknownNCT02992392Not applicable
- Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02986750Phase 4
- Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02980913Not applicable
- Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland DysfunctionCompletedNCT02958514Not applicable
- A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry EyeCompletedNCT02951910Phase 4
- Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD)Status unknownNCT02943382Not applicable
- Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye SyndromeCompletedNCT02917512Phase 2
- Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry EyeCompletedNCT02908282Not applicable
- Interest of Eye Movement Measurements in the Comprehension of Dry Eyes SymptomsCompletedNCT02851654
- Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.Status unknownNCT02849093
- The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye DiseaseCompletedNCT02802150Not applicable
- Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With PterygiumStatus unknownNCT02782260Phase 2
- Study to Evaluate the Efficacy and Safety of CKD-350Status unknownNCT02777723Phase 3
- Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye SyndromeStatus unknownNCT02774707